News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: oncoredox > Uncategorized > OncoRedox: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

OncoRedox: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

18. October 2023 - 14:53 (CEST)

Gesamtstimmrechte | 18 Oktober 2023 14:53

OncoRedox / Total Voting Rights Announcement
OncoRedox: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
18.10.2023 / 14:53 CET/CEST
Total Voting Rights Announcement transmitted by EQS News – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Publication of total number of voting rights

1. Details of issuer

OncoRedox
Bertha-Benz-Straße 5
10557 Berlin
Germany

2. Type of capital measure

Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 18.10.2023
Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:

4267087

18.10.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: OncoRedox
Bertha-Benz-Straße 5
10557 Berlin
Germany
Internet: www.oncoredox.com
End of News EQS News Service

News Categories

Media Contact

Frederic Hilke (IR.on AG) T +49 221 9140-9719 ir@oncoredox.com
/>